An Investigation on Breast Cancer Knowledge in Developing Nations
DOI:
https://doi.org/10.47957/ijciar.v7i2.179Keywords:
Breast cancer, Tumour, PR, HER2, TIL, PDL1Abstract
Breast cancer is the most common malignant tumor in women diagnosed globally and the leading cause of cancer-related death. Globally, the prevalence of breast cancer is increasing with time. Globally, breast cancer is the most prevalent type of cancer. The incidence of breast cancer is linked to several risk factors, such as genetic and inherited predispositions. Breast cancers can be of many different forms. The molecular features of breast cancer, such as the activation of hormone receptors (PR, ER, and HER2) and human epidermal growth factor receptor 2, genetic alterations (BRCA1/2 and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [PIK3CA] mutations), and immune system markers (PD L1, tumour-infiltrating lymphocytes [TIL], and programmed death-ligand 1 [PD L1]) may impact treatment strategies. sufferers.
Downloads
References
Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing?. Annals of Surgical Oncology. 2004 Aug;11:751-5. https://pubmed.ncbi.nlm.nih.gov/15289238/ DOI: https://doi.org/10.1245/ASO.2004.01.001
Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Rosenblatt DN, Thune I, Vieira R, Norat T. Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies. Annals of oncology. 2014 Oct 1;25(10):1901-14. DOI: https://doi.org/10.1093/annonc/mdu042
Nardin S, Mora E, Varughese FM, D'Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A. Breast cancer survivorship, quality of life, and late toxicities. Frontiers in oncology. 2020 Jun 16;10:864. DOI: https://doi.org/10.3389/fonc.2020.00864
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory. Cancer today. 2018;23(7):323-6.
Pisipati SV, Pathapati H, Bhukya G, Nuthakki S, Chandu B, Nama S, Adeps R. Lycopene: Redress for prostate cancer. Journal of Basic and Clinical Pharmacy. 2012 Mar;3(2):261. DOI: https://doi.org/10.4103/0976-0105.103818
Francies FZ, Hull R, Khanyile R, Dlamini Z. Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options. American journal of cancer research. 2020;10(5):1568.
Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. The lancet oncology. 2010 Dec 1;11(12):1135-41. DOI: https://doi.org/10.1016/S1470-2045(10)70257-6
Rani TT, Brahmaiah B, Revathi B, Nama S, Baburao C. TARGETING OF ANTI CANCER DRUGS THROUGH NANOPARTICLES.
Gianni L, Pienkowski T, Im YH, Tseng LM, Liu MC, Lluch A, Starosławska E, de la Haba-Rodriguez J, Im SA, Pedrini JL, Poirier B. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. The lancet oncology. 2016 Jun 1;17(6):791-800. DOI: https://doi.org/10.1016/S1470-2045(16)00163-7
Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2020 Apr 1;18(4):452-78. DOI: https://doi.org/10.6004/jnccn.2020.0016
Kang SY, Lee SB, Kim YS, Kim Z, Kim HY, Kim HJ, Park S, Bae SY, Yoon K, Lee SK, Jung KW. Breast cancer statistics in Korea, 2018. Journal of breast cancer. 2021 Apr;24(2):123. DOI: https://doi.org/10.4048/jbc.2021.24.e22
Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine. 2021 Aug 1;38. DOI: https://doi.org/10.1016/j.eclinm.2021.100985
Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer epidemiology, biomarkers & prevention. 2017 Apr 1;26(4):444-57. DOI: https://doi.org/10.1158/1055-9965.EPI-16-0858
Martin N, Buykx P, Shevills C, Sullivan C, Clark L, Newbury-Birch D. Population level effects of a mass media alcohol and breast cancer campaign: a cross-sectional pre-intervention and post-intervention evaluation. Alcohol and Alcoholism. 2018 Jan 1;53(1):31-8. DOI: https://doi.org/10.1093/alcalc/agx071
Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nature Reviews Cancer. 2012 Jan;12(1):68-78. DOI: https://doi.org/10.1038/nrc3181
Published
How to Cite
Issue
Section
Citations
This work is licensed under a Creative Commons Attribution 4.0 International License.
